Venture financing for mRNA-based vaccines declines 82% in 2025 YTD
Venture financing for companies developing innovator mRNA-based drugs more than halved from $1.1m in 2023 to $488m in 2024.
Venture financing for companies developing innovator mRNA-based drugs more than halved from $1.1m in 2023 to $488m in 2024.